Knight Therapeutics Inc. (GUD.TO) - Stock Prices, Stock Peers & Analysis

Home
GUD.TO

Company Name	Knight Therapeutics Inc.
Symbol	GUD.TO
Currency	CAD
Price	5.64
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	570,846,960
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	4.35 - 6.22
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Ms. Samira Sakhia BCom, CA, CPA, MBA
Website	https://www.gud-knight.com

An error occurred while fetching data.

About Knight Therapeutics Inc.

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib